2025: Volume 8, Issue 1
Commentary P.1-2
Monoclonal Antibodies vs. Traditional Therapies: A Comparative Analysis
Author(s):
Ann Yun
DOI: 10.35841/aajcit-8.1.246
Commentary P.1-2
T-Cell Activation: Mechanisms, Pathways, and Immune Response
Author(s):
Chongbo Shang
DOI: 10.35841/aajcit-8.1.247
Opinion Article P.1-2
Natural Killer (NK) Cells in Adoptive Cell Therapy: A New Era of Cancer Treatment
Author(s):
Haohan Guo
DOI: 10.35841/aajcit-8.1.248
Opinion Article P.1-2
From Lab to Clinic: The Development and Production of Monoclonal Antibodies
Author(s):
Kanna Sridharan
DOI: 10.35841/aajcit-8.1.249
Perspective P.1-2
The Molecular Signaling Pathways of T-Cell Activation
Author(s):
Qian Shi
DOI: 10.35841/aajcit-8.1.250
Perspective P.1-2
Combination Therapies: Enhancing the Efficacy of Adoptive Cell Therapy
Author(s):
Reuven Proost
DOI: 10.35841/aajcit-8.1.251
Rapid Communication P.1-2
Challenges and Future Directions in Adoptive Cell Therapy
Author(s):
Shan Peng
DOI: 10.35841/aajcit-8.1.252
Rapid Communication P.1-2
Personalized Medicine and Adoptive Cell Therapy: The Future of Cancer Care
Author(s):
Alan Sanderson
DOI: 10.35841/aajcit-8.1.253
Short Communication P.1-2
Expanding the Frontiers of Immunotherapy: Advances in Adoptive Cell Therapy
Author(s):
Jonathan Nair
DOI: 10.35841/aajcit-8.1.254
Short Communication P.1-2
Future Directions in Modulating T-Cell Activation for Disease Treatment
Author(s):
Xue Wang
DOI: 10.35841/aajcit-8.1.255